Management of menopause in primary health care.

Detalhes bibliográficos
Autor(a) principal: Cavadas, Luís Filipe
Data de Publicação: 2010
Outros Autores: Nunes, Ana, Pinheiro, Marisa, Silva, Pedro Tiago
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/612
Resumo: Menopause is a biological process that occurs as part of aging in women. The increase in average life expectancy and the decline in mortality have caused the aging of global population and, currently, women live about a third of their life in postmenopausal. The General Physician (GP) is usually the first health professional whom women rely on to relieve their menopause symptoms. It is essential for the GP to know how to properly approach women at this stage of their life and how to provide them the best support.To evaluate women in perimenopause and postmenopausal, to recognize its signs and symptoms, and to use properly the Hormone Replacement Therapy (HRT) in Primary Health Care (PHC).We performed a literature search in the PubMed database using the MeSH terms: Menopause, Hormone Replacement Therapy, Primary Health Care. The search was limited to articles published between January 2000 and March 2009 in English, Portuguese and Spanish. Recommendations from Scientific Societies were also searched.During menopause women are more predisposed to change their habits and to adopt healthy lifestyles. The GP plays a key role in health promotion among these women. The most common complaints that lead women to the PHC during perimenopause are vasomotor symptoms, sleep disorders, weight gain, uterine bleeding, urogenital and sexual changes and disturbances of mood and memory. The use of HRT is only recommended for the control of severe vasomotor symptoms that affect women's quality of life, as well as for vaginal atrophy and urinary symptoms. It should be used for a short period of time and in the lowest dose. It is important for the GP to know the existing formulations, the way of administration and the correct monitoring of this therapy.Women experience physical and psychological changes during perimenopause and postmenopausal, resulting from aging and hypoestrogenism. It is essential that the GP recognizes the symptoms and their impact on quality of life of women, offering treatment when necessary. The HRT and its follow-up can be performed in PHC, if the GP know how to use this type of treatment.
id RCAP_3294dec4e7c763b23850b3031cd6e2bd
oai_identifier_str oai:ojs.www.actamedicaportuguesa.com:article/612
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Management of menopause in primary health care.Abordagem da menopausa nos cuidados de saúde primários.Menopause is a biological process that occurs as part of aging in women. The increase in average life expectancy and the decline in mortality have caused the aging of global population and, currently, women live about a third of their life in postmenopausal. The General Physician (GP) is usually the first health professional whom women rely on to relieve their menopause symptoms. It is essential for the GP to know how to properly approach women at this stage of their life and how to provide them the best support.To evaluate women in perimenopause and postmenopausal, to recognize its signs and symptoms, and to use properly the Hormone Replacement Therapy (HRT) in Primary Health Care (PHC).We performed a literature search in the PubMed database using the MeSH terms: Menopause, Hormone Replacement Therapy, Primary Health Care. The search was limited to articles published between January 2000 and March 2009 in English, Portuguese and Spanish. Recommendations from Scientific Societies were also searched.During menopause women are more predisposed to change their habits and to adopt healthy lifestyles. The GP plays a key role in health promotion among these women. The most common complaints that lead women to the PHC during perimenopause are vasomotor symptoms, sleep disorders, weight gain, uterine bleeding, urogenital and sexual changes and disturbances of mood and memory. The use of HRT is only recommended for the control of severe vasomotor symptoms that affect women's quality of life, as well as for vaginal atrophy and urinary symptoms. It should be used for a short period of time and in the lowest dose. It is important for the GP to know the existing formulations, the way of administration and the correct monitoring of this therapy.Women experience physical and psychological changes during perimenopause and postmenopausal, resulting from aging and hypoestrogenism. It is essential that the GP recognizes the symptoms and their impact on quality of life of women, offering treatment when necessary. The HRT and its follow-up can be performed in PHC, if the GP know how to use this type of treatment.Menopause is a biological process that occurs as part of aging in women. The increase in average life expectancy and the decline in mortality have caused the aging of global population and, currently, women live about a third of their life in postmenopausal. The General Physician (GP) is usually the first health professional whom women rely on to relieve their menopause symptoms. It is essential for the GP to know how to properly approach women at this stage of their life and how to provide them the best support.To evaluate women in perimenopause and postmenopausal, to recognize its signs and symptoms, and to use properly the Hormone Replacement Therapy (HRT) in Primary Health Care (PHC).We performed a literature search in the PubMed database using the MeSH terms: Menopause, Hormone Replacement Therapy, Primary Health Care. The search was limited to articles published between January 2000 and March 2009 in English, Portuguese and Spanish. Recommendations from Scientific Societies were also searched.During menopause women are more predisposed to change their habits and to adopt healthy lifestyles. The GP plays a key role in health promotion among these women. The most common complaints that lead women to the PHC during perimenopause are vasomotor symptoms, sleep disorders, weight gain, uterine bleeding, urogenital and sexual changes and disturbances of mood and memory. The use of HRT is only recommended for the control of severe vasomotor symptoms that affect women's quality of life, as well as for vaginal atrophy and urinary symptoms. It should be used for a short period of time and in the lowest dose. It is important for the GP to know the existing formulations, the way of administration and the correct monitoring of this therapy.Women experience physical and psychological changes during perimenopause and postmenopausal, resulting from aging and hypoestrogenism. It is essential that the GP recognizes the symptoms and their impact on quality of life of women, offering treatment when necessary. The HRT and its follow-up can be performed in PHC, if the GP know how to use this type of treatment.Ordem dos Médicos2010-04-14info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/612oai:ojs.www.actamedicaportuguesa.com:article/612Acta Médica Portuguesa; Vol. 23 No. 2 (2010): March-April; 227-36Acta Médica Portuguesa; Vol. 23 N.º 2 (2010): Março-Abril; 227-361646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/612https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/612/296Cavadas, Luís FilipeNunes, AnaPinheiro, MarisaSilva, Pedro Tiagoinfo:eu-repo/semantics/openAccess2022-12-20T10:56:35Zoai:ojs.www.actamedicaportuguesa.com:article/612Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:16:37.423716Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Management of menopause in primary health care.
Abordagem da menopausa nos cuidados de saúde primários.
title Management of menopause in primary health care.
spellingShingle Management of menopause in primary health care.
Cavadas, Luís Filipe
title_short Management of menopause in primary health care.
title_full Management of menopause in primary health care.
title_fullStr Management of menopause in primary health care.
title_full_unstemmed Management of menopause in primary health care.
title_sort Management of menopause in primary health care.
author Cavadas, Luís Filipe
author_facet Cavadas, Luís Filipe
Nunes, Ana
Pinheiro, Marisa
Silva, Pedro Tiago
author_role author
author2 Nunes, Ana
Pinheiro, Marisa
Silva, Pedro Tiago
author2_role author
author
author
dc.contributor.author.fl_str_mv Cavadas, Luís Filipe
Nunes, Ana
Pinheiro, Marisa
Silva, Pedro Tiago
description Menopause is a biological process that occurs as part of aging in women. The increase in average life expectancy and the decline in mortality have caused the aging of global population and, currently, women live about a third of their life in postmenopausal. The General Physician (GP) is usually the first health professional whom women rely on to relieve their menopause symptoms. It is essential for the GP to know how to properly approach women at this stage of their life and how to provide them the best support.To evaluate women in perimenopause and postmenopausal, to recognize its signs and symptoms, and to use properly the Hormone Replacement Therapy (HRT) in Primary Health Care (PHC).We performed a literature search in the PubMed database using the MeSH terms: Menopause, Hormone Replacement Therapy, Primary Health Care. The search was limited to articles published between January 2000 and March 2009 in English, Portuguese and Spanish. Recommendations from Scientific Societies were also searched.During menopause women are more predisposed to change their habits and to adopt healthy lifestyles. The GP plays a key role in health promotion among these women. The most common complaints that lead women to the PHC during perimenopause are vasomotor symptoms, sleep disorders, weight gain, uterine bleeding, urogenital and sexual changes and disturbances of mood and memory. The use of HRT is only recommended for the control of severe vasomotor symptoms that affect women's quality of life, as well as for vaginal atrophy and urinary symptoms. It should be used for a short period of time and in the lowest dose. It is important for the GP to know the existing formulations, the way of administration and the correct monitoring of this therapy.Women experience physical and psychological changes during perimenopause and postmenopausal, resulting from aging and hypoestrogenism. It is essential that the GP recognizes the symptoms and their impact on quality of life of women, offering treatment when necessary. The HRT and its follow-up can be performed in PHC, if the GP know how to use this type of treatment.
publishDate 2010
dc.date.none.fl_str_mv 2010-04-14
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/612
oai:ojs.www.actamedicaportuguesa.com:article/612
url https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/612
identifier_str_mv oai:ojs.www.actamedicaportuguesa.com:article/612
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/612
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/612/296
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Ordem dos Médicos
publisher.none.fl_str_mv Ordem dos Médicos
dc.source.none.fl_str_mv Acta Médica Portuguesa; Vol. 23 No. 2 (2010): March-April; 227-36
Acta Médica Portuguesa; Vol. 23 N.º 2 (2010): Março-Abril; 227-36
1646-0758
0870-399X
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799130619951710208